BR112015008324A2 - método de aprimoramento de aparência de pele em envelhecimento através da modulação de wipi-1 - Google Patents

método de aprimoramento de aparência de pele em envelhecimento através da modulação de wipi-1

Info

Publication number
BR112015008324A2
BR112015008324A2 BR112015008324A BR112015008324A BR112015008324A2 BR 112015008324 A2 BR112015008324 A2 BR 112015008324A2 BR 112015008324 A BR112015008324 A BR 112015008324A BR 112015008324 A BR112015008324 A BR 112015008324A BR 112015008324 A2 BR112015008324 A2 BR 112015008324A2
Authority
BR
Brazil
Prior art keywords
wipi
modulating
skin appearance
enhancement method
aging skin
Prior art date
Application number
BR112015008324A
Other languages
English (en)
Inventor
W Lyga John
Raaj Khusial Permanan
Santhanam Uma
Original Assignee
Avon Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avon Prod Inc filed Critical Avon Prod Inc
Publication of BR112015008324A2 publication Critical patent/BR112015008324A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/148—Screening for cosmetic compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Dermatology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Pathology (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

resumo “método de aprimoramento de aparência de pele em envelhecimento através da modulação de wipi-1” trata-se de métodos de uso de wipi-1 para conferir benefícios de antienve-lhecimento à pele e/ou aprimorar as condições cutâneas resultantes de atividade de autofagia reduzida.
BR112015008324A 2012-12-11 2013-10-16 método de aprimoramento de aparência de pele em envelhecimento através da modulação de wipi-1 BR112015008324A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261735649P 2012-12-11 2012-12-11
PCT/US2013/065194 WO2014092859A1 (en) 2012-12-11 2013-10-16 Method of improving aging appearance of skin by modulation of wipi-1

Publications (1)

Publication Number Publication Date
BR112015008324A2 true BR112015008324A2 (pt) 2017-07-04

Family

ID=50881204

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015008324A BR112015008324A2 (pt) 2012-12-11 2013-10-16 método de aprimoramento de aparência de pele em envelhecimento através da modulação de wipi-1

Country Status (8)

Country Link
US (3) US9238000B2 (pt)
EP (1) EP2931383A4 (pt)
CN (1) CN104736204A (pt)
BR (1) BR112015008324A2 (pt)
CA (1) CA2886506A1 (pt)
HK (1) HK1209074A1 (pt)
TW (1) TW201422246A (pt)
WO (1) WO2014092859A1 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112012015446B1 (pt) 2009-12-22 2020-02-11 Avon Products, Inc. Composição tópica e método para conferir um benefício antienvelhecimento à pele
US20110159125A1 (en) 2009-12-29 2011-06-30 Avon Products, Inc. CGRP Compositions and Uses Thereof
PL2588593T3 (pl) 2010-06-30 2018-01-31 Avon Prod Inc Kompozycje i sposoby stymulowania MAGP-1 dla poprawy wyglądu skóry
US10195136B2 (en) 2011-08-24 2019-02-05 Avon Products, Inc. Collagen and elastin stimulating compositions and uses thereof
TW201422246A (zh) * 2012-12-11 2014-06-16 Avon Prod Inc 藉由調節ｗｉｐｉ－１改善皮膚老化外觀之方法
EP3305370B1 (en) 2016-10-04 2021-03-10 Chemisches Laboratorium Dr. Kurt Richter GmbH Algae autophagy activator
US10543158B2 (en) * 2017-04-17 2020-01-28 W Skincare, LLC Autophagy activating complex, compositions and methods
EP3654960A1 (en) 2017-07-16 2020-05-27 Neuere, LLC Ambroxol to improve and/or extend healthspan, lifespan and/or mental acuity
JP7369716B2 (ja) * 2018-01-26 2023-10-26 ノイレ， エルエルシー 皮膚バリア機能を改善するためのアンブロキソールの使用
BR112020024715A2 (pt) 2018-06-04 2021-03-23 Avon Products. Inc. biomarcadores proteicos para identificar e tratar o envelhecimento da pele e afecções cutâneas
CN108703911B (zh) * 2018-08-10 2020-06-05 广东卓明仕生物科技有限公司 一种具有保湿美白功效的组合物及其制备方法和应用
CN109010414B (zh) * 2018-09-29 2021-11-16 广州安加农业发展有限公司 猴耳环提取物在预防和/或治疗高尿酸血症和与高尿酸血症相关的代谢性病症中的应用
WO2023156069A1 (en) * 2022-02-18 2023-08-24 The Boots Company Plc Cosmetic composition comprising extract of ophiopogon japonicus and at least one ceramide

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4322438A (en) * 1979-08-06 1982-03-30 United States Of America Method for the use of orally administered 13-cis-retinoic acid in the treatment of acne
CN1057461C (zh) * 1996-11-07 2000-10-18 孙红 天然祛斑美容品
US6146640A (en) * 1998-08-31 2000-11-14 Dyke; John Paul Immune system catalyst
JP4280340B2 (ja) 1998-10-28 2009-06-17 一丸ファルコス株式会社 保湿性植物抽出物を含有する化粧料組成物
US7108982B1 (en) 1999-02-19 2006-09-19 University Of Iowa Research Foundation Diagnostics and the therapeutics for macular degeneration
JP4532706B2 (ja) 2000-09-08 2010-08-25 花王株式会社 化粧料
US6884783B2 (en) 2002-05-03 2005-04-26 Unigen Pharmaceuticals, Inc. 7-Hydroxy chromones as potent antioxidants
US20050136028A1 (en) 2003-12-19 2005-06-23 Dmitri Ptchelintsev Cosmetic compositions having extracts of Amomum melegueta and methods of treating skin
US20050196450A1 (en) 2004-03-04 2005-09-08 Elka Touitou Method and composition for burned skin
US20060024390A1 (en) 2004-07-27 2006-02-02 Alex Schauss Palm fiber-based dietary supplements
JP5041569B2 (ja) 2004-09-01 2012-10-03 丸善製薬株式会社 チロシナーゼ活性阻害剤、美白剤及び皮膚化粧料
US7618662B2 (en) 2004-12-22 2009-11-17 Avon Products, Inc Use of natural plant extracts in cosmetic compositions
US8221766B2 (en) 2004-12-22 2012-07-17 Avon Products, Inc. Use of plant extracts to prevent and/or reduce the signs of subjective discomfort and/or irritation in the topical application of cosmetic products
CN100548321C (zh) * 2004-12-29 2009-10-14 广州莱泰医药科技有限公司 猴耳环提取物用于制备抗过敏药物、食品及化妆品的应用
EP1984387B1 (en) 2006-02-16 2017-05-31 Sederma Polypeptides kxk and their use
CN101099839A (zh) 2007-07-09 2008-01-09 汪朝田 一种外用中药药包及其使用方法
CN101129675B (zh) 2007-07-10 2010-11-17 郑学东 治疗风湿、类风湿的外用帖膏
US8440636B2 (en) 2007-07-31 2013-05-14 The Board Of Regents, The University Of Texas System Micro-RNA family that modulates fibrosis and uses thereof
CN101234153B (zh) 2007-12-27 2010-11-10 卢旭 治疗骨折的外用药物
WO2009134404A2 (en) 2008-04-30 2009-11-05 New York University Of School Of Medicine Steroidal compounds as melanogenesis modifiers and uses thereof
JP2010090069A (ja) 2008-10-09 2010-04-22 Shiseido Co Ltd 美白剤および皮膚外用剤
FR2939316B1 (fr) * 2008-12-05 2012-08-10 Limousine D Applic Biolog Ditesilab Soc Ind Utilisation cosmetique d'activateurs de l'autophagie des cellules cutanees.
US20100166677A1 (en) * 2008-12-30 2010-07-01 Avon Products, Inc. Use of Tiliacora Triandra in Cosmetics and Compositions Thereof
CN101559033A (zh) 2009-05-20 2009-10-21 黎秋萍 草药花泡沫沐浴剂与护肤胶囊
BR112012015446B1 (pt) 2009-12-22 2020-02-11 Avon Products, Inc. Composição tópica e método para conferir um benefício antienvelhecimento à pele
US8815265B2 (en) 2010-06-30 2014-08-26 Avon Products, Inc. Cosmetic use of N-substituted sulfonyloxybenzylamines and related compounds
EP2588062B1 (en) * 2010-06-30 2019-05-29 Avon Products, Inc. Use of tiliacora triandra in cosmetics and compositions thereof
US8771758B2 (en) 2010-06-30 2014-07-08 Avon Products, Inc. Use of Tiliacora triandra in cosmetics and compositions thereof
PL2588593T3 (pl) * 2010-06-30 2018-01-31 Avon Prod Inc Kompozycje i sposoby stymulowania MAGP-1 dla poprawy wyglądu skóry
US8455518B2 (en) 2010-12-28 2013-06-04 Avon Products, Inc. Method of treating skin with microRNA modulators
CA2831597C (en) 2011-03-28 2020-10-13 Mary Kay Inc. Topical skin care formulations comprising plant extracts
US10195136B2 (en) * 2011-08-24 2019-02-05 Avon Products, Inc. Collagen and elastin stimulating compositions and uses thereof
US8686013B2 (en) * 2011-08-25 2014-04-01 Avon Products, Inc. Cosmetic use of substituted amino heterocylic carbamoyl analogs and related compounds
US9289365B2 (en) * 2011-10-24 2016-03-22 Avon Products, Inc. Compositions and methods for stimulating collagen synthesis in the skin
WO2013086405A1 (en) 2011-12-09 2013-06-13 Homma Michael Mitsuo Long lasting fingernail lacquer and method for manufacture
WO2013090228A2 (en) * 2011-12-13 2013-06-20 Avon Products, Inc. Maesa japonica extracts and methods of use
US8632827B2 (en) * 2011-12-13 2014-01-21 Avon Products, Inc Modulation of thymosin beta-4 in skin
US8927517B2 (en) 2012-04-27 2015-01-06 Kao Corporation Factors controlling skin and hair color
US9186316B2 (en) * 2012-12-11 2015-11-17 Avon Products, Inc. Stephanotis jasminoides extracts and methods of use
TW201422246A (zh) * 2012-12-11 2014-06-16 Avon Prod Inc 藉由調節ｗｉｐｉ－１改善皮膚老化外觀之方法
US9034396B2 (en) * 2012-12-11 2015-05-19 Avon Products, Inc. Serissa japonica extracts and methods of use
BR112017019054B1 (pt) * 2015-03-05 2021-05-11 Avon Products, Inc método cosmético, não terapêutico, para diminuir sinais dermatológicos de envelhecimento em pele humana e produtos para cuidados com a pele

Also Published As

Publication number Publication date
CN104736204A (zh) 2015-06-24
HK1209074A1 (en) 2016-03-24
TW201422246A (zh) 2014-06-16
US9675543B2 (en) 2017-06-13
CA2886506A1 (en) 2014-06-19
EP2931383A1 (en) 2015-10-21
US20140161916A1 (en) 2014-06-12
US9238000B2 (en) 2016-01-19
EP2931383A4 (en) 2016-08-24
WO2014092859A1 (en) 2014-06-19
US20160089327A1 (en) 2016-03-31
US20150190339A1 (en) 2015-07-09

Similar Documents

Publication Publication Date Title
BR112015008324A2 (pt) método de aprimoramento de aparência de pele em envelhecimento através da modulação de wipi-1
CY1123958T1 (el) Μεθοδος παρασκευης παραγωγων και ενδιαμεσων καρβαμοϋλπυριδονης
BR112014013172A2 (pt) extratos de maesa japonica e métodos de uso
BR112017023872A2 (pt) anticorpos anti-cd166, anticorpos anti-cd166 ativáveis e métodos de uso dos mesmos
CO7151485A2 (es) Anticuerpos anti-sez6 y métodos de empleo
BR112016002391A2 (pt) composições tópicas e métodos de uso das mesmas
CO7111274A2 (es) Moduladores dll3 y métodos de empleo
BR112015010772A2 (pt) composição de enxágue tópica, uso de uma composição e método para tratar ou melhorar a pele de um indivíduo contra a acne
EA201390929A1 (ru) Антитела к pcsk9 и способы их применения
EA201171396A1 (ru) Лечение портальной гипертензии и восстановление функции печени с помощью l-орнитинфенилацетата
EA201491357A1 (ru) Анти-lrp5 антитела и способы их применения
BR112013000768A2 (pt) asparaginase de basidiomicetos
EA201390704A1 (ru) Соединения, ингибирующие металлоферменты
BR112013016935A2 (pt) modulação da dineína na pele
BR112013022234A2 (pt) emulsão de dodecafluorpentano como uma terapia de acidente vascular cerebral e isquemia
BR112014002595A2 (pt) uso de esfinganina para melhorar a aparência visual da pele e cabelo
IN2014MN02392A (pt)
AU2017310412A8 (en) Method of improving connective tissue attachment using anti-sclerostin antibodies
BR112018005315A2 (pt) abordagens para aprimorar hidratação ou umidificação de pele
BR112013003846A2 (pt) métodos de tratamento de celulite
MX2015012580A (es) El uso de sdf-1 para atenuar la formacion de cicatrices.
PH12015502577B1 (en) Modulation of heparin-binding epidermal growth factor activity for tympanic membrane healing
WO2014092684A3 (en) Use of melicope extracts to improve conditions caused by excess lipids
EA201391821A1 (ru) Гелевые композиции
ES2723177T3 (es) Promotor de la producción de bleomicina hidrolasa

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according art. 34 industrial property law
B06F Objections, documents and/or translations needed after an examination request according art. 34 industrial property law
B06I Technical and formal requirements: publication cancelled

Free format text: ANULADA A PUBLICACAO CODIGO 6.6.1 NA RPI NO 2462 DE 13/03/2018 POR TER SIDO INDEVIDA.

B08F Application fees: dismissal - article 86 of industrial property law
B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2484 DE 14-08-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.